pegargiminase,Pemetrexed,Cisplatin,pembrolizumab,Nivolumab,Ipilimumab
polaris pharma,Merck,BMS
['atomic', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'prism', 'nivo', 'colorectal', 'ca,022,i', 'toripalimab', 'niche-2', 'ca,022,1', 'dostarlimab', 'ipilimumab', 'neoprism-crc', 'rectal', 'celecoxib', 'sintilimab', 'pembro']
checkpoint inhibitors in msi-h colorectal cancer at #wcgic2023 excellent overview by test in every stage! we need predictive biomarker current evidence &amp; ongoing studies such as atomic, neoprism-crc, ea2201 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision oncology